2021
Interim clinical trial analysis of intraoperative mass spectrometry for breast cancer surgery
Basu SS, Stopka SA, Abdelmoula WM, Randall EC, Gimenez-Cassina Lopez B, Regan MS, Calligaris D, Lu FF, Norton I, Mallory MA, Santagata S, Dillon DA, Golshan M, Agar NYR. Interim clinical trial analysis of intraoperative mass spectrometry for breast cancer surgery. Npj Breast Cancer 2021, 7: 116. PMID: 34504095, PMCID: PMC8429658, DOI: 10.1038/s41523-021-00318-5.Peer-Reviewed Original ResearchIntraoperative mass spectrometrySurgical marginsBreast cancerTime of surgeryInvasive breast cancerBreast cancer surgeryRegistered clinical trialsBreast cancer tissuesBreast cancer marginsClinical trial analysisPost-surgery analysisSuch resectionsCancer surgerySurgical specimensClinical trialsHistopathological determinationOptimal resectionUninvolved regionsCancer tissuesTumor breastBreast tumorsCandidate biomarkersLipidomic profilesPathological techniquesNormal tissues
2014
Genetic Predisposition to Breast Cancer
Golshan M. Genetic Predisposition to Breast Cancer. 2014, 263-264. DOI: 10.1007/978-1-4939-1565-1_66.Peer-Reviewed Original ResearchBreast cancer casesBreast cancerCancer casesInvasive breast cancerCancer-related deathOvarian cancer accountsHereditary breast cancerCancer accountsCommon cancerLifetime riskMutation carriersGenetic predispositionBRCA2 genesCancerWomenAmerican womenPredispositionBRCA1Large proportionBreastDiseaseCases
2011
P2-08-02: Magnetic Resonance Imaging as a Predictor of Pathologic Response in Patients Treated with Neoadjuvant Systemic Treatment for Operable Breast Cancer (TBCRC 017).
De L, Cantor A, Mcguire K, Golshan M, Meric-Bernstam F, Horton J, Nanda R, Amos K, Forero A, Hudis C, Meszoely I, Hwang S. P2-08-02: Magnetic Resonance Imaging as a Predictor of Pathologic Response in Patients Treated with Neoadjuvant Systemic Treatment for Operable Breast Cancer (TBCRC 017). Cancer Research 2011, 71: p2-08-02-p2-08-02. DOI: 10.1158/0008-5472.sabcs11-p2-08-02.Peer-Reviewed Original ResearchRadiographic complete responseNeoadjuvant systemic therapyInvasive breast cancerSystemic therapyBreast cancerHR-/HER2Systemic treatmentTumor gradePathologic complete response rateTumor phenotypeBasis of estrogenComplete response rateOperable breast cancerMulticenter retrospective studyNeoadjuvant systemic treatmentMorbidity of surgeryHER2 receptor statusPrediction of pCRBreast cancer subtypesMagnetic resonance imagingHR-HER2IHC phenotypeChemotherapy regimenNeoadjuvant chemotherapyTN subtypeSurgical margins and the risk of local-regional recurrence (LRR) following mastectomy for early-stage breast cancer.
Childs S, Chen Y, Pochebit S, Golshan M, Duggan M, Wong J, Harris J, Bellon J. Surgical margins and the risk of local-regional recurrence (LRR) following mastectomy for early-stage breast cancer. Journal Of Clinical Oncology 2011, 29: 95-95. DOI: 10.1200/jco.2011.29.27_suppl.95.Peer-Reviewed Original ResearchLocal-regional recurrenceRisk of LRRInvasive diseaseSurgical marginsSuperficial marginsDeep marginBreast cancerEarly-stage breast cancerPositive axillary nodesClose surgical marginsDistant metastasis rateKaplan-Meier methodPost-mastectomy radiationDeep surgical marginsInvasive breast cancerLRR ratePositive nodesAxillary nodesFirst recurrenceLymphovascular invasionPure DCIST3 tumorsConsecutive womenMedian ageMetastasis rate
2008
Young Breast Cancer Patients Undergoing Breast-Conserving Therapy: Role of BRCA1 and BRCA2
Bafford A, Garber J, Chittenden A, Golshan M. Young Breast Cancer Patients Undergoing Breast-Conserving Therapy: Role of BRCA1 and BRCA2. Methods Of Cancer Diagnosis, Therapy And Prognosis 2008, 1: 483-491. DOI: 10.1007/978-1-4020-8369-3_33.Peer-Reviewed Original ResearchBreast cancerYoung breast cancer patientsTumor suppressor geneBreast-Conserving TherapyInvasive breast cancerBreast cancer patientsCancer-related deathSporadic breast cancerSuppressor geneClassical tumor suppressor geneCancer patientsCommon cancerCancerRole of BRCA1WomenAmerican womenBRCA2BRCA1Cell cycle regulationDNA damageMultiple cellular processesPatientsTherapyDiseaseDiagnosisInvasive Breast Cancer
Golshan M. Invasive Breast Cancer. 2008, 337-339. DOI: 10.1007/978-0-387-75246-4_83.Peer-Reviewed Original Research